Memoryspex

01/06/2026

Your most important upgrade this year isn’t software.
It’s your .
Why is rising and how is leading a brain health revolution ↓
hypersence.com/blog/2025/12/5…

You can return to our homepage by clicking here, or you can try searching for the content you are seeking by clicking here.

11/04/2025

Four years ago, I survived what should have killed me.

I spent months learning to walk, talk, and rebuild my life—and in the process, I rediscovered my mission.

Long before my aneurysm, I created MemorySPEX®, a wearable that uses light and AI to enhance brain health. What I couldn’t have known was that this innovation would one day inspire my own recovery.

Today, I’m stronger, grateful, and preparing to launch MemorySPEX globally at CES 2026 in Las Vegas.

I didn’t survive by chance. I survived to finish what I started.

💫 Read the full story https://hypersence.com/blog/2025/10/30/from-hospital-bed-to-global-launch

08/29/2025

Thrilled to share that I’ll be pitching MemorySPEX® at the AgeInnovate Pitch Showcase on September 17 in Nashville.
We’re pioneering non-invasive light + AI to enhance cognitive performance—as easy as putting on glasses—and helping people achieve dreams of a better life.

If you’re passionate about Age Tech, brain health, wearables, or health innovation, join us and meet an incredible community of investors and innovators.

👉 Register: https://bit.ly/AgeInnovate

AgeInnovate Pitch Event is back for a second year to shine a light on the creative solutions supporting the senior care ecosystem.

12/06/2022

We're excited to announce that Heugenis has changed its name to HYPERSENCE! We are focusing on delivering wearable tech to help millions achieve dreams of a better life! Now, as easy as putting on glasses, users can supercharge their brains and gain competitive advantage at work and at school. We're taking pre-orders for our groundbreaking wearable tech MemorySPEX for $400, a discount of $600! Contact me at [email protected] to learn more!

12/01/2020

Hi everyone,
I'm so excited to pitch Heugenis and our patent-pending, non-drug treatment for TONIGHT through Traverse City New Tech pitch competition. Winners are chosen by popular vote, so please tune in and watch these great entrepreneurs pitch and vote for HEUGENIS! Thank you! Click the link below to register!

A select group of startup founders will pitch their new business or technology ideas then our audience votes via text for the best idea.

11/02/2020

Heugenis is excited to announce our participation in Stanford University's Global Innovation Catalyst. "On behalf of our world class team at Heugenis, I’m honored to participate in GIC and excited to see how it will energize and empower our mission to bring hope to 46 million desperate Alzheimer’s sufferers globally. — Kim Lavine - Founder/CEO" (read more…

The Global Innovation Catalyst is a 12 week program designed to drive innovation globally through an immersive curriculum built around experiential learning. Described as a “Stanford MBA in a box,” participants complete coursework in Business Model Assessment, Go To Market Strategy, Product Deve...

09/09/2020

So excited and honored to pitch www.heugenis.com and our patent-pending non-drug treatment for Alzheimer's at StartupGrind's "Champion Startup Showcase!" We had great comments from organizers and VC's in attendance, who said we're headed to "unicorn" status and a billion dollar valuation in record time! We're heading on to the global competition round, where we will compete with startups from around the world! 🤞 Bringing hope to millions!

08/06/2020

Heugenis.com is excited to announce that we are a part of the @ [Nashville Entrepreneur Center]’s 2020 Project Healthcare cohort! We will be joining 30 other Service and Device companies across 4 stages to exponentially grow our business. Follow along on our journey at ec.co/project-healthcare.

Project Healthcare is Nashville’s leading healthcare entrepreneurship initiative: driving transformation in the healthcare industry through tailored programming and connections critical to success in this highly competitive landscape.

08/05/2020

Selected from over 750 applicants, Heugenis was selected to pitch recently at the WomenWhoTech challenge and top Silicon Valley VCs had great things to say about their patent-pending, non-drug treatment for 46M desperate Alzheimer's sufferers.

Heugenis and Founder/CEO Kim Lavine were 1 of 5 finalists selected out of 750+ applicants for the Women Who Tech Challenge

08/01/2020

So honored and excited to announce that our company www.heugenis.com and our patent-pending non-drug treatment for Alzheimer's was chosen as one of five finalists out of 750+ applicants to pitch at the national competition www.womenwhotech.com! Watch the 5 minute video here, talking about our exciting technology and successes to date, including its use by NBA superstar Steph Curry, clinical trial at Cedars Sinai, as well as being vetted by an international Pharmaceutical company with operations in 200+ countries https://bit.ly/Heugenis_Pitch

Bringing hope to millions suffering from Alzheimer's with an easy to use, low cost, non-drug approach. Our 40Hz stroboscopic treatment of Alzheimer's leverages cutting-edge research.